Vector-related Tumorigenesis Not Found in Ornithine Transcarbamylase-deficient Mice

Molecular Therapy

Volumn 14, Issue 1, 2006, Pages 1-2

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; ORNITHINE CARBAMOYLTRANSFERASE; PARVOVIRUS VECTOR;

AUTOPSY; CANCER RISK; CARCINOGENICITY; DIET THERAPY; EDITORIAL; ENZYME DEFICIENCY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HETEROZYGOTE; HUMAN; HYPERAMMONEMIA; LETHALITY; LIVER CARCINOGENESIS; LIVER TRANSPLANTATION; LIVER TUMOR; LYSOSOME STORAGE DISEASE; METABOLIC DISORDER; MOUSE STRAIN; NONHUMAN; SOUTHERN BLOTTING; TRANSGENE; VIRAL GENE THERAPY; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

EID: 33745117625     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.05.011     Document Type: Editorial

References (12)

1. H. Morizono Enhanced rescue of OTC deficiency using novel adeno-associated virus vectors Mol. Genet. Metab. 84 2005 230 231
2. P. Bell Analysis of Tumors Arising in Male B6C3F1 Mice with and without AAV Vector Delivery to Liver Mol. Ther. 14 2006 34 45
3. D. Moscioni Long-Term Correction of Ammonia Metabolism and Prolonged Survival in Ornithine Transcarbamylase-Deficient Mice Following Liver-Directed Treatment with Novel Adeno-associated Viral Vectors Mol. Ther. 14 2006 25 33
4. J.M. Saudubray Liver transplantation in urea cycle disorders Eur. J. Pediatr. 158 Suppl 2 1999 S55 S59
5. S.E. Raper Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency J. Inherit. Metab. Dis. 21 Suppl 1 1998 119 137
6. S.E. Raper Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer Mol. Genet. Metab. 80 2003 148 158
7. G.P. Gao Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc. Natl. Acad. Sci. USA 99 2002 11854 11859
8. A. Donsante Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors Gene Ther. 8 2001 1343 1346
9. A. Ghosh Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer Gene Ther. 13 2006 321 329
10. D.D. Koeberl Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia Gene Ther. 2006 Epub ahead of press.
11. A. Buchmann Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis Proc. Natl. Acad. Sci. USA 88 1991 911 915
12. P. Bell No evidence for tumorigenesis of AAV vectors in a large-scale study in mice Mol. Ther. 12 2005 299 306